Publication Name	World Journal of Virology
Manuscript ID	61775
Country	Japan

Received	2020-12-18 06:35
Peer-Review Started	2020-12-18 06:38
To Make the First Decision
Return for Revision	2021-01-07 18:37
Revised	2021-01-16 02:41
Second Decision	2021-02-03 09:54
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-02-20 05:47
Articles in Press	2021-02-20 05:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-03-13 08:08
Publish the Manuscript Online	2021-03-16 09:17

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza
Manuscript Source	Invited Manuscript
All Author List	Masafumi Seki
ORCID	Author(s) ORCID Number Masafumi Seki http://orcid.org/0000-0001-5414-8148
Funding Agency and Grant Number
Corresponding Author	Masafumi Seki, MD, Professor, Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University, Fukumuro 1-12-1, Miyagino-ku, Miyagi 983-8536, Japan. m-seki@tohoku-mpu.ac.jp
Key Words	COVID-19; SARS-CoV-2; Influenza; Angiotensin-converting enzyme 2; Vaccine; Alveolar flood
Core Tip	We are focusing the differences and similarity of coronavirus disease 2019 (COVID-19) and Influenza, and review the characteristic pathophysiology and basic concepts of treatment and prevention for COVID-19. Primary influenza pneumonia is known to exist in addition to secondary bacterial pneumonia, however, pulmonary edema (alveolar flood) from a similar cytokine storm, as well as severe angiopathy should be considered in COVID-19.
Publish Date	2021-03-16 09:17
Citation	Seki M. Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza. World J Virol 2021; 10(2): 62-68
URL	https://www.wjgnet.com/2220-3249/full/v10/i2/62.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i2.62

Full Article (PDF)	WJV-10-62.pdf
Full Article (Word)	WJV-10-62.docx
Manuscript File	61775_Auto_Edited_LM.docx
Answering Reviewers	61775-Answering reviewers.pdf
Audio Core Tip	61775-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	61775-Conflict-of-interest statement.pdf
Copyright License Agreement	61775-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	61775-Language certificate.pdf
Peer-review Report	61775-Peer-review(s).pdf
Scientific Misconduct Check	61775-Scientific misconduct check.pdf
Scientific Editor Work List	61775-Scientific editor work list.pdf
CrossCheck Report	61775-CrossCheck report.pdf